BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8994411)

  • 1. Methylenetetrahydrofolate reductase gene and coronary artery disease.
    van Bockxmeer FM; Mamotte CD; Vasikaran SD; Taylor RR
    Circulation; 1997 Jan; 95(1):21-3. PubMed ID: 8994411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease.
    Verhoef P; Kok FJ; Kluijtmans LA; Blom HJ; Refsum H; Ueland PM; Kruyssen DA
    Atherosclerosis; 1997 Jul; 132(1):105-13. PubMed ID: 9247365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylenetetrahydrofolate reductase 677 C-->T mutation and coronary heart disease risk in UK Indian Asians.
    Chambers JC; Ireland H; Thompson E; Reilly P; Obeid OA; Refsum H; Ueland P; Lane DA; Kooner JS
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2448-52. PubMed ID: 11073851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease.
    Christensen B; Frosst P; Lussier-Cacan S; Selhub J; Goyette P; Rosenblatt DS; Genest J; Rozen R
    Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):569-73. PubMed ID: 9102178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population.
    Nair KG; Nair SR; Ashavaid TF; Dalal JJ; Eghlim FF
    J Assoc Physicians India; 2002 May; 50 Suppl():9-15. PubMed ID: 12186157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction.
    Girelli D; Friso S; Trabetti E; Olivieri O; Russo C; Pessotto R; Faccini G; Pignatti PF; Mazzucco A; Corrocher R
    Blood; 1998 Jun; 91(11):4158-63. PubMed ID: 9596662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common mutation in the methylenetetrahydrofolate reductase gene and risk of coronary heart disease: results among U.S. men.
    Verhoef P; Rimm EB; Hunter DJ; Chen J; Willett WC; Kelsey K; Stampfer MJ
    J Am Coll Cardiol; 1998 Aug; 32(2):353-9. PubMed ID: 9708460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation.
    Gallagher PM; Meleady R; Shields DC; Tan KS; McMaster D; Rozen R; Evans A; Graham IM; Whitehead AS
    Circulation; 1996 Nov; 94(9):2154-8. PubMed ID: 8901666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of a common mutation in methylenetetrahydrofolate reductase to plasma homocysteine and early onset coronary artery disease.
    Dunn J; Title LM; Bata I; Johnstone DE; Kirkland SA; O'Neill BJ; Zayed E; MacDonald MC; Dempsey G; Nassar B
    Clin Biochem; 1998 Mar; 31(2):95-100. PubMed ID: 9622772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylenetetrahydrofolate reductase genotypes and early-onset coronary artery disease.
    Mager A; Lalezari S; Shohat T; Birnbaum Y; Adler Y; Magal N; Shohat M
    Circulation; 1999 Dec; 100(24):2406-10. PubMed ID: 10595952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The high prevalence of thermolabile 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD).
    Abbate R; Sardi I; Pepe G; Marcucci R; Brunelli T; Prisco D; Fatini C; Capanni M; Simonetti I; Gensini GF
    Thromb Haemost; 1998 Apr; 79(4):727-30. PubMed ID: 9569181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
    Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperhomocysteinemia, MTHFR C677T genotype and low folate levels: a risk combination for acute coronary disease in a Portuguese population.
    Araújo F; Lopes M; Gonçalves L; Maciel MJ; Cunha-Ribeiro LM
    Thromb Haemost; 2000 Mar; 83(3):517-8. PubMed ID: 10744169
    [No Abstract]   [Full Text] [Related]  

  • 14. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.
    Jacques PF; Bostom AG; Williams RR; Ellison RC; Eckfeldt JH; Rosenberg IH; Selhub J; Rozen R
    Circulation; 1996 Jan; 93(1):7-9. PubMed ID: 8616944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and the risk of coronary artery disease.
    Reinhardt D; Sigusch HH; Vogt SF; Farker K; Müller S; Hoffmann A
    Eur J Clin Invest; 1998 Jan; 28(1):20-3. PubMed ID: 9502183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of a common methylenetetrahydrofolate reductase mutation and plasma homocysteine with intimal hyperplasia after coronary stenting.
    Kosokabe T; Okumura K; Sone T; Kondo J; Tsuboi H; Mukawa H; Tomida T; Suzuki T; Kamiya H; Matsui H; Hayakawa T
    Circulation; 2001 Apr; 103(16):2048-54. PubMed ID: 11319193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease.
    Kluijtmans LA; Kastelein JJ; Lindemans J; Boers GH; Heil SG; Bruschke AV; Jukema JW; van den Heuvel LP; Trijbels FJ; Boerma GJ; Verheugt FW; Willems F; Blom HJ
    Circulation; 1997 Oct; 96(8):2573-7. PubMed ID: 9355896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease.
    Deloughery TG; Evans A; Sadeghi A; McWilliams J; Henner WD; Taylor LM; Press RD
    Circulation; 1996 Dec; 94(12):3074-8. PubMed ID: 8989110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction.
    Adams M; Smith PD; Martin D; Thompson JR; Lodwick D; Samani NJ
    QJM; 1996 Jun; 89(6):437-44. PubMed ID: 8758047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation A1298C of methylenetetrahydrofolate reductase: risk for early coronary disease not associated with hyperhomocysteinemia.
    Szczeklik A; Sanak M; Jankowski M; Dropiński J; Czachór R; Musiał J; Axenti I; Twardowska M; Brzostek T; Tendera M
    Am J Med Genet; 2001 Jun; 101(1):36-9. PubMed ID: 11343335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.